ALZHEON, INC.
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-09-109/10/26 | New | $78,797,184 | $78,797,184 | Equity Only | 06b | SEC linkSEC |
| 2025-02-102/10/25 | Amended | $126,259,938 | $1,259,907 | Equity Only | 06c | SEC linkSEC |
| 2025-01-021/2/25 | Amended | $125,000,031 | $107,750,140 | Equity Only | 06c | SEC linkSEC |
| 2024-03-123/12/24 | New | $17,249,891 | $17,249,891 | Equity Only | 06b | SEC linkSEC |
| 2023-01-111/11/23 | New | $1,703,768 | $1,703,768 | Equity Only | 06b | SEC linkSEC |
| 2020-09-309/30/20 | New | $2,432,016 | $2,432,016 | Equity Only | 06b | SEC linkSEC |
| 2020-01-151/15/20 | New | $6,163,716 | $6,163,716 | Equity Only | 06b | SEC linkSEC |
| 2018-09-059/5/18 | Amended | $19,801,820 | $4,037,721 | Equity Only | 06b | SEC linkSEC |
| 2017-06-096/9/17 | New | $15,764,099 | $15,764,099 | Equity Only | 06b | SEC linkSEC |
| 2016-02-262/26/16 | New | $1,300,000 | $1,300,000 | Debt Only | 06b | SEC linkSEC |
| 2015-07-277/27/15 | New | $6,905,000 | $6,905,000 | Debt Only | 06b | SEC linkSEC |
| 2015-02-252/25/15 | Amended | $7,344,629 | $4,294,629 | Equity Only | 06b | SEC linkSEC |
| 2015-01-091/9/15 | New | $3,050,000 | $3,050,000 | Equity Only | 06b | SEC linkSEC |
| 2013-12-1612/16/13 | Amended | $550,000 | $220,000 | Debt Only | 06b | SEC linkSEC |
| 2013-07-317/31/13 | New | $330,000 | $330,000 | Debt Only | 06 | SEC linkSEC |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Susan Abushakra, M.D. | Executive |
| Michael Aceti | Executive |
| Adem Albayrak | Executive |
| Menghis Bairu | Director |
| Franklin Berger | Director |
| Adam Hale Brockman | Executive |
| Christopher Noel Dunn | Director |
| Noel Dunn | Director |
| Neil W. Flanzraich | Director |
| Jean Pierre Garnier | Director |
| Franz Hefti | Director |
| Jordan Heller | Director |
| John Hey | Executive |
| John Hey, Ph.D. | Executive |
| Diane K. Jorkasky, M.D. | Director |
| Dennis Langer | Director |
| Ken Mace | Executive |
| Kenneth Mace | Executive |
| Gregory Leon Miller | Executive |
| Scott Minick | Director |
| David Nikodem | Director |
| David Nikodem, Ph.D. | Director |
| Glenn E. Pauly | Executive |
| Aidan Power, Mrc Psych | Executive |
| Gino Santini | Director |
| Muneer Sateer | Director |
| Muneer Satter | Director |
| Robert Silverman | Executive |
| Jean Pierre Sommadossi | Director |
| Martin Tolar | Director, Executive |
| Martin Tolar, M.D., Ph.D. | Director, Executive |
| Mark Versavel | Executive |
| Jeremy Yongxin Yu | Executive |
Industry: Biotechnology (See others in industry)
Address:
111 Speen Street Suite 306
Framingham, MA, 01701
Phone: 508-861-7709
Framingham, MA, 01701
Phone: 508-861-7709